Type 2 diabetes care: Improvement by standardization at a diabetes rehabilitation clinic. An observational report

被引:9
|
作者
Haslacher, Helmuth [1 ]
Fallmann, Hannelore [2 ]
Waldhaeusl, Claudia [3 ]
Hartmann, Edith [2 ]
Wagner, Oswald F. [1 ]
Waldhaeusl, Werner [2 ,4 ]
机构
[1] Med Univ Vienna, Dept Lab Med, Vienna, Austria
[2] Rehabil Clin Diabet & Metab Dis, Neydharting, Neydharting, Austria
[3] Med Univ Vienna, Dept Radiotherapy, Vienna, Austria
[4] Med Univ Vienna, Dept Med 3, Vienna, Austria
来源
PLOS ONE | 2019年 / 14卷 / 12期
关键词
MULTIFACTORIAL INTERVENTION; ASSOCIATION; PREVALENCE; REMISSION; PROGRAM; WEIGHT;
D O I
10.1371/journal.pone.0226132
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Outcome of type 2 diabetes care depends on the acceptance of self-responsibility by informed patients, as treatment goals will otherwise be missed. Aims and methods This pre/post-observational report describes the clinical outcome of type 2 diabetes care in patients with type 2 diabetes (N=930) admitted consecutively to a diabetes rehabilitation clinic (DRC) between June 2013, and June 2016, where they were exposed to standardized lifestyle modification with meals low in salt and rich in vegetables and fruits, totaling 1,200 to 1,600 kcal/d, and an add-on exercise load equivalent to 400-600 kcal/d. Results At admission, patients presented with multiple treatment modes, elevated HbA(1c) levels (7.6 +/- 1.5%, 60 +/- 16 mmol/mol), a high prevalence of co-morbidities dominated by obesity (79%), a low rate of influenza and pneumococcal immunization (<9%) and underuse of lipid-lowering drugs (-29%). Analysis of clinical and metabolic outcome after 3 weeks shows that simple standardization of and better adherence to treatment recommendations improved (p<0.0001) glucose (HbA(1c) -0.4 +/- 0.4%) and lipid metabolism (LDL/HDL ratio, -0.58 +/- 0.03), permitting a 39% reduction in insulin dosage, omission of insulin in 36/232 patients and omission of oral antidiabetic drugs (OADs) other than metformin and DPP4-inhibitors, while the use of GLP-1 analogs doubled to 5.2%. Improved outcome was independent of treatment strategy and more marked at initially high HbA(1c) at costs less than 25% of those encountered at a standard hospital. Conclusions Our observations support the clinical notion that adherence to basic treatment recommendations is indispensable in type 2 diabetes care if metabolic and clinical treatment goals are to be met, and if inappropriate add-on over-medicalization with OADs and/or insulin is to be avoided. To this end, 'imprinting' patients at a DRC could be of considerable help.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Type 1 diabetes care: Improvement by standardization in a diabetes rehabilitation clinic. An observational report
    Haslacher, Helmuth
    Fallmann, Hannelore
    Waldhaeusl, Claudia
    Hartmann, Edith
    Wagner, Oswald F.
    Waldhaeusl, Werner
    [J]. PLOS ONE, 2018, 13 (03):
  • [2] An evaluation of patients with diabetes followed by a pharmaceutical care clinic.
    Earl, MA
    Fink, JM
    Cristiani, CA
    [J]. PHARMACOTHERAPY, 2005, 25 (10): : 1500 - 1500
  • [3] Improving diabetes care in a rural family medicine clinic.
    Andrus, MR
    Murphey, LM
    Herndon, KC
    [J]. PHARMACOTHERAPY, 2002, 22 (10): : 1376 - 1377
  • [4] Evaluating metformin based dual therapy of individuals with type 2 diabetes mellitus in a primary care clinic.
    Zitko, Kimberly L.
    Drew, Amy M.
    Smith, Carmen B.
    [J]. PHARMACOTHERAPY, 2016, 36 (12): : E232 - E232
  • [5] Incidence and treatment of metabolic syndrome in adolescents enrolled in a type 2 diabetes clinic.
    Harris, BN
    West, DS
    Lubsch, LM
    [J]. PHARMACOTHERAPY, 2004, 24 (10): : 1433 - 1433
  • [6] Outcome of diabetes patients attending a hospital diabetes clinic.
    Siu, SC
    Lo, SK
    Wong, CKW
    [J]. DIABETOLOGIA, 2003, 46 : A434 - A434
  • [7] Evaluation of a pharmacist managed diabetes clinic.
    Aneese, Nadia
    Halalau, Alexandra
    Lauster, Colleen
    Muench, Sarah
    Fett, Janna
    [J]. PHARMACOTHERAPY, 2016, 36 (07): : E116 - E117
  • [8] Impact of pharmacist involvement in a diabetes management clinic.
    Ramsey, LA
    Bouldin, M
    Ligon, A
    Murphey, LM
    Rochester, CD
    Pitcock, JJ
    Pitcock, MB
    [J]. PHARMACOTHERAPY, 2003, 23 (03): : 420 - 420
  • [9] Guidelines for diabetes care: Type 2 diabetes
    Schatz, H
    Voigt, KH
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 (07) : 389 - 389
  • [10] Diabetes risk factors and testing in a family medicine clinic.
    Dallo, F. J.
    Weller, S. C.
    Cass, A. R.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : S185 - S185